Vir and Alnylam to Webcast Virtual Fireside Chat at H.C. Wainwright Hepatitis B Virus Mini-Conference
SAN FRANCISCO and CAMBRIDGE, Mass., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that Phil Pang, M.D., Ph.D., Chief Medical Officer of Vir, and Vasant Jadhav, Ph.D., Vice President, Research at Alnylam, will jointly participate in a virtual fireside chat at the H.C. Wainwright Hepatitis B Virus Mini-Conference on Tuesday, October 20, 2020 at 9:30 am PT/ 12:30 pm ET via webcast.
A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there following the presentation for 30 days. A live audio webcast of the presentation will also be available on the Investors section of Alnylam’s website at www.alnylam.com/events. A replay will be available on the Alnylam website within 48 hours after the event.
About Vir Biotechnology
About Alnylam Pharmaceuticals
Contact: Vir Biotechnology, Inc. Investors Neera Ravindran, MD VP, Head of Investor Relations & Strategic Communications email@example.com +1-415-506-5256 Media Cara Miller VP, Corporate Communications firstname.lastname@example.org +1-415-941-6746 Alnylam Pharmaceuticals, Inc. Christine Regan Lindenboom (Investors and Media) +1-617-682-4340 Josh Brodsky (Investors) +1-617-551-8276